DH

David Ho

Scientific Advisor at Apexigen

David D. Ho is the founding Scientific Director and Chief Executive Officer of the Aaron Diamond AIDS Research Center, a world-renowned biomedical research institute. He is also the Irene Diamond Professor at The Rockefeller University.

Dr. Ho received his degrees from the California Institute of Technology and Harvard Medical School. Subsequently, he did his clinical training in internal medicine and infectious diseases at Cedars-Sinai Medical Center/UCLA School of Medicine and Massachusetts General Hospital/Harvard Medical School, respectively.

Dr. David Ho has been at the forefront of AIDS research for 33 years, publishing over 400 papers. His elegant studies, beginning in 1994, unveiled the dynamic nature of HIV replication in vivo and revolutionized the basic understanding of this horrific disease. This knowledge led Dr. Ho to champion combination antiretroviral therapy that resulted in unprecedented control of HIV in patients. AIDS mortality in richer nations has declined dramatically since 1996, and a massive international effort is now underway to bring such life-saving treatment to millions in the developing world. To date over 10 million patients have benefitted from combination antiretroviral therapy. Dr. Ho has been the major driving force behind this major medical breakthrough in what is arguably the worst plague in human history.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Apexigen

Apexigen is a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the treatment of cancer with an emphasis on new immuno-oncology products.


Industries

Employees

11-50

Links